Bioventus Inc.
Bioventus Inc. (BVS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bvs · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$13.00
Consensus
$13.00
+43.8% upside
Low
$13.00
Median: $13 · Last Close: $9.04
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.59 | ↓ 5.00% |
1-day model range: $8.53–$8.65. Peak: $8.65 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $11 | +22.5% |
| 2028 | $12 | +37.6% |
| 2029 | $13 | +46.9% |
| 2030 | $14 | +52.4% |
| 2031 | — | +55.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BVS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-06 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-03-06 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-12-17 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2024-11-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-09-27 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy→Buy |
| 2024-08-07 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-05-08 | Canaccord Genuity | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bioventus Inc. (BVS) stock. Of the recent 31 rating actions, 2 were upgrades and 4 were downgrades. 6 analysts currently cover BVS.
Analyst Recommendation Trends
BVS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$605M
↓ 11.7% YoY
Revenue Next Year
$645M
↑ 6.6% YoY
EPS This Year
$0.78
EPS Next Year
$0.91
↑ 16.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast BVS EPS of $0.78 for the current fiscal year, based on estimates from 4 analysts. The BVS revenue forecast is $605M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BVS stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BVS price target is $13.00 (+43.8% upside), with an analyst consensus of Buy.
The BVS short-term stock prediction for tomorrow is $8.59 (-5.00%). The BVS stock price prediction for 2027 estimates an average of $11. The BVS stock prediction for 2030 projects a range of $13–$15.
Bioventus Inc. trades on NASDAQ under the ticker BVS. The BVS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
BVS forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month BVS price target is $13.00, with a high forecast of $13.00 and a low of $13.00. The median price target is shown in the chart above when available. This implies +43.8% potential upside from the current price of $9.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.